Arcus Biosciences, Inc. Cash Flow Statement

Cash Flow Statement Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -52.67M-49.94M-85.14M-123.00M53.00M-267.00M-307.00M-283.00M
Share-based Compensation 0.09M0.49M3.87M8.98M22.00M55.00M65.00M73.00M76.00M
Gains from Sales and Divestitures 0.06M0.01M0.37M0.01M0.38M0.50M
Gains from Investment Securities 1.20M1.86M1.46M4.74M9.89M12.00M12.00M14.00M-22.00M
Asset Writedowns and Impairment 20.00M
Non-cash Items 1.90M0.24M1.15M2.79M5.16M50.00M
Cash from Operations -12.94M-25.06M-43.00M-73.46M111.00M-256.00M438.00M-306.00M-170.00M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 1.75M2.64M1.00M-5.00M8.00M19.00M25.00M
Depreciation & Amortization (CF) 1.31M2.61M3.66M3.58M3.00M4.00M6.00M8.00M10.00M
Change in Working Capital
Change in Account Payables 3.57M-0.27M-0.07M1.73M9.00M-5.00M8.00M-1.00M3.00M
Change in Accured Expenses 0.81M1.58M1.87M1.76M13.73M10.14M
Other Working Capital Changes 0.60M23.59M1.18M-2.00M188.00M-368.00M-112.00M-68.00M-56.00M
Investing Activities
Capital Expenditures 4.10M5.51M3.74M1.93M3.00M26.00M6.00M24.00M6.00M
Change in Acquisitions & Divestments 53.27M151.85M308.89M307.34M690.07M
Cash from Investing Activities -38.86M-49.07M-113.44M59.21M-434.00M-4.00M-413.00M194.00M-84.00M
Financing Activities
Other financing activities 0.14M
Cash from Financing Activities 70.10M107.40M129.07M1.12M439.00M237.00M33.00M33.00M277.00M
Additional items
Change in Cash 18.30M33.27M-27.36M-13.13M116.00M-23.00M58.00M-79.00M23.00M
Free Cash Flow -17.04M-30.57M-46.74M-75.39M108.00M-282.00M432.00M-330.00M-176.00M
Net Cash Flow 18.30M33.27M-27.36M-13.13M116.00M-23.00M58.00M-79.00M23.00M